FACULTY
Peter A. Lio, MD
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University
Evanston, Illinois
Amy Paller, MD
Program Chair
Chair, Department of Dermatology
Director, Skin Biology and Diseases Resource-Based Center
Walter J. Hamlin Professor of Dermatology
Northwestern Medicine Feinberg School of Medicine
Chicago, Illinois
PROGRAM OVERVIEW
This enduring activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
TARGET AUDIENCE
This enduring activity is intended for dermatologists, pediatric dermatologists, pediatricians, primary care physicians, and other health care professionals involved in managing pediatric and adolescent patients with atopic dermatitis.
LEARNING OBJECTIVES
On completing the program, attendees should be able to:
- Develop treatment plans for managing atopic dermatitis in pediatric and adolescent patients that incorporate guideline recommendations, evidence from clinical trials, and patient-specific factors
- Identify patients who would benefit from treatment intensification based on disease severity, failure of prior therapy, and comorbid conditions
- Incorporate strategies into clinical practice that encourage patient-centered and multidisciplinary care of atopic dermatitis
ACCREDITATION AND DESIGNATION STATEMENTS
PHYSICIAN
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES
This program would be beneficial for nurses involved in the treatment and management of pediatric and adolescent patients with atopic dermatitis.
CNE Credits:
1.0 ANCC Contact Hour
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
| SPEAKER | RELATIONSHIP | RELATIONSHIPS |
| Peter A. Lio, MD | Consultant | L’Oreal USA Inc., Franklin BioScience, AbbVie, Kiniksa Pharmaceuticals, Ltd, Eli Lilly and Company, Unilever, Dermira, TopMD, Amyris, Inc. LEO Laboratories Ltd (LEO Pharma), Odeza LLC, Theraplex, Exeltis, and Burt’s Bees |
| Speaker | La Roche-Posay Laboratorie Pharmaceutique, Pierre Fabre Dermatologie, Regeneron, Theraplex, and Pfizer Inc. |
|
| Advisory Board | Menlo Therapeutics, DermVeda, gpower, inc., UCB, Altus Labs, Dermavant Sciences, Micreos Human Health B.V., Verrica Pharmaceuticals Inc, Arbonne, Johnson & Johnson Consumer Products Company, DermTap, Inc, Modernizing Medicine, IntraDerm Pharmaceuticals, Regeneron, Sanofi US Services, Realm Therapeutics, National Eczema Association, modernizing medicine, and Syncere Skin Systems | |
| Investigator | La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis), AOBiome, LLC, Regeneron, AbbVie | |
| Stockholder | Modernizing Medicine, LearnHealth/LearnSkin, and Medable | |
| Amy Paller, MD (Program Chair) | Consultant | AbbVie, Almirall, AnaptysBio, Asana, Boehringer-Ingelheim, Dermavant, Dermira, Eli Lilly, Forte, Galderma, Leo, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, and Sol Gel |
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Planners
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Diana Tommasi, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group has nothing
Sharine Griggs, Senior Program Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating in and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Complete pre and post survey.
- Submit the evaluation form online.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making experience before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected].
RELEASE DATE: January 11, 2021
EXPIRATION DATE: January 11, 2022
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the enduring event at [email protected].
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
